Evidence map›Paper›PMID 35397038›Full record

ArticleObesity surgery2022

Lipid Accumulation Product Predicts Diabetes Remission After Bariatric Surgery in Chinese Patients with BMI < 35 kg/m

Xianhao Yi, Jiapu Ling, Hua Meng, Liangping Wu, Shaihong Zhu, Liyong Zhu

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xianhao Yi *Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
Jiapu Ling *Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
Hua MengDepartment of General Surgery, The China-Japan Friendship Hospital, Beijing, China. menghuade@hotmail.com.
Liangping WuDepartment of Metabolic Surgery, The Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. drwulp@163.com.
Shaihong ZhuDepartment of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. shzhu@csu.edu.cn.
Liyong ZhuDepartment of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. zly8128@csu.edu.cn.ORCID http://orcid.org/0000-0003-2696-4177
Central South University · CNChina-Japan Friendship Hospital · CNGuangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate whether preoperative visceral fat-related indexes, such as visceral adiposity index (VAI), lipid accumulation product (LAP), Chinese visceral adiposity index (CVAI), and metabolic score for visceral fat (METS-VF), are useful for predicting diabetes remission in Chinese patients with a BMI < 35 kg/m MATERIALS AND

methodsA retrospective, multicenter cohort study enrolled 177 patients. Binary logistic regression and receiver operating characteristic (ROC) curves were used to identify predictors and clinically useful cutoff values, respectively. The correlation between the visceral fat-related index and body fat percentage was assessed.

resultsComplete remission of type 2 diabetes (T2DM) was observed in 66 patients (37.29%) 1 year after surgery. The VAI, LAP, CVAI, and METS-VF showed downward trends postsurgery. Patients with complete remission had a significantly shorter duration of diabetes and higher CVAI, VAI, LAP, and BMI values than those without complete remission. Binary logistic regression and ROC analysis confirmed that diabetes duration and LAP can predict diabetes remission after bariatric surgery, and a LAP of 67.725 is a useful threshold for predicting surgical efficacy. LAP was significantly positively correlated with VAT/total (%) (p < 0.05).

conclusionPreoperative LAP is a feasible tool for predicting T2DM remission in patients with a BMI < 35 kg/m

Indexed as

Bariatric SurgeryDiabetes Mellitus, Type 2Lipid Accumulation ProductObesity, MorbidAdiposityBody Mass IndexChinaCohort StudiesHumansObesity, AbdominalRetrospective StudiesBariatric surgeryBMI < 35 kg/m2Lipid accumulation productType 2 diabetes remission

Identifiers

PMID35397038
OpenAlexW4223428425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.